Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Baird Medical Investment Holdings Limited before investing.

In this article, we go over a few key elements for understanding Baird Medical Investment Holdings Limited’s stock price such as:

• Baird Medical Investment Holdings Limited’s current stock price and volume
• Why Baird Medical Investment Holdings Limited’s stock price changed recently
• Upgrades and downgrades for BDMD from analysts
• BDMD’s stock price momentum as measured by its relative strength

About Baird Medical Investment Holdings Limited (BDMD)

Before we jump into Baird Medical Investment Holdings Limited’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Want to learn more about Baird Medical Investment Holdings Limited’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Baird Medical Investment Holdings Limited.

Baird Medical Investment Holdings Limited’s Stock Price as of Market Close

As of July 31, 2026, 2:11 PM, CST, Baird Medical Investment Holdings Limited’s stock price was $1.030.

Baird Medical Investment Holdings Limited is down 0.96% from its previous closing price of $1.040.

During the last market session, Baird Medical Investment Holdings Limited’s stock traded between $0.995 and $1.080. Currently, there are approximately 29.18 million shares outstanding for Baird Medical Investment Holdings Limited.

Baird Medical Investment Holdings Limited’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Baird Medical Investment Holdings Limited Stock Price History

Baird Medical Investment Holdings Limited’s (BDMD) price is currently down 10.43% so far this month.

During the month of July, Baird Medical Investment Holdings Limited’s stock price has reached a high of $1.300 and a low of $0.960.

Over the last year, Baird Medical Investment Holdings Limited has hit prices as high as $3.750 and as low as $0.757. Year to date, Baird Medical Investment Holdings Limited’s stock is down 24.26%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Baird Medical Investment Holdings Limited Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were analysts who downgraded Baird Medical Investment Holdings Limited’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Baird Medical Investment Holdings Limited’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Baird Medical Investment Holdings Limited’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Baird Medical Investment Holdings Limited’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Baird Medical Investment Holdings Limited (BDMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Baird Medical Investment Holdings Limited

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Baird Medical Investment Holdings Limited has a weighted four-quarter relative price strength of -18.10%, which translates to a Momentum Score of 13 and is considered to be Very Weak.

Want to learn more about how Baird Medical Investment Holdings Limited is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Baird Medical Investment Holdings Limited Stock Price: Bottom Line

As of July 31, 2026, Baird Medical Investment Holdings Limited’s stock price is $1.030, which is down 0.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Baird Medical Investment Holdings Limited stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.